expanding its global patent portfolio to over 120, which includes 80 issued patents and over 40 pending applications. The company focuses on addressing cancers involving the nervous system ...
Femasys plans to expand its patent portfolio further, including over 180 global patents, to protect its suite of women's health products. FemaSeed is positioned as a safe, affordable, and ...
Under the terms of this agreement, The TPL Group is granted full responsibility and authority for the commercialization and licensing of the unified patents portfolio. This significant joint accord ...